Kamada KMDA
NASDAQ KMDA
$8.69 +0.07 (+0.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kamada (KMDA) EBIT (2012 - 2026)

Updated

Kamada's EBIT was $9.51 million in the quarter ended Jun 30, 2026, up 34.5% from $7.07 million a year earlier and up 36.8% from the prior quarter.

Analysis

Kamada (KMDA) EBIT (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Kamada's EBIT was $27.83 million through Jun 30, 2026, up 10.3% year-over-year; for the year ended Dec 31, 2025, it came in at $26.23 million, up 30.8% from the prior year.

  • EBIT has now increased for three consecutive years, with a five-year compound annual growth rate of 6.4% (years ended Dec 2020 to Dec 2025).
  • In earlier years, EBIT was $20.05 million in the year ended Dec 31, 2024 (+99.2%), $10.06 million in the year ended Dec 31, 2023 (+122.1%), $4.53 million in the year ended Dec 31, 2022 and -$696,000 in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly EBIT since the quarter ended Dec 31, 2018.
  • Compared with a year earlier, EBIT was higher in six of the last eight quarters, with growth averaging 33.0%.
  • The best year-over-year quarter for EBIT over five years was the quarter ended Jun 30, 2024 (growth of 114.4%); the worst was the quarter ended Mar 31, 2022 (a decline of 89.6%).
  • Per Business Quant data, KMDA's EBIT in the three quarters before the quarter ended Jun 30, 2026 was $6.95 million (quarter ended Mar 31, 2026), $3.55 million (quarter ended Dec 31, 2025) and $7.82 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 7.14 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.43 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 3.16 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Kamada 497.25 Mn 206.31 Mn 22.47 Mn 9.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.51 Mn
Mar 31, 2026 6.95 Mn
Dec 31, 2025 3.55 Mn
Sep 30, 2025 7.82 Mn
Jun 30, 2025 7.07 Mn
Mar 31, 2025 7.80 Mn
Dec 31, 2024 5.08 Mn
Sep 30, 2024 5.29 Mn
Jun 30, 2024 5.64 Mn
Mar 31, 2024 4.04 Mn
Dec 31, 2023 2.78 Mn
Sep 30, 2023 4.37 Mn
Jun 30, 2023 2.63 Mn
Mar 31, 2023 289,000.00
Dec 31, 2022 4.02 Mn
Sep 30, 2022 2.56 Mn
Jun 30, 2022 -2.29 Mn
Mar 31, 2022 246,000.00
Dec 31, 2021 -3.30 Mn
Sep 30, 2021 -804,000.00
API Access

Kamada EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=KMDA&period=max&api_key=YOUR_API_KEY